Revolution Medicines Inc (RVMD)
37.56 x 1 44.00 x 2
Post-market by (Cboe BZX)
36.76 +0.56 (+1.55%) 04/17/25 [NASDAQ]
37.56 x 1 44.00 x 2
Post-market 37.50 +0.74 (+2.01%) 16:51 ET
for Thu, Apr 17th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -600,093 | -436,367 | -248,705 | -187,091 | -108,159 |
Depreciation Amortization | -32,741 | -12,896 | 6,578 | 10,344 | 7,513 |
Income taxes - deferred | -762 | -3,910 | -419 | N/A | -375 |
Accounts receivable | 1,254 | 3,419 | 1,256 | 464 | 2,344 |
Accounts payable and accrued liabilities | -6,465 | 32,469 | 7,288 | 2,239 | 305 |
Other Working Capital | 1,168 | 40,662 | -13,070 | 8,724 | -7,929 |
Other Operating Activity | 80,203 | 26,051 | 22,671 | 18,140 | 6,237 |
Operating Cash Flow | $-557,436 | $-350,572 | $-224,401 | $-147,180 | $-100,064 |
Cash Flows From Investing Activities | |||||
Change In Deposits | -544,086 | -334,869 | -13,300 | -135,589 | -231,300 |
PPE Investments | -10,308 | -7,729 | -10,816 | -6,528 | -2,933 |
Investing Cash Flow | $-554,394 | $-342,598 | $-24,116 | $-142,117 | $-234,233 |
Cash Flows From Financing Activities | |||||
Common Stock Issued | 959,129 | 1,233,226 | 301,390 | 294,603 | 422,776 |
Other Financing Activity | 284 | -4,026 | 42 | -424 | 0 |
Financing Cash Flow | $959,413 | $1,229,200 | $301,432 | $294,179 | $422,776 |
Beginning Cash Position | 699,179 | 163,149 | 110,234 | 105,352 | 16,873 |
End Cash Position | 546,762 | 699,179 | 163,149 | 110,234 | 105,352 |
Net Cash Flow | $-152,417 | $536,030 | $52,915 | $4,882 | $88,479 |
Free Cash Flow | |||||
Operating Cash Flow | -557,436 | -350,572 | -224,401 | -147,180 | -100,064 |
Capital Expenditure | -10,308 | -7,729 | -10,816 | -6,528 | -2,933 |
Free Cash Flow | -567,744 | -358,301 | -235,217 | -153,708 | -102,997 |